Multiple meningiomas: Investigating the molecular basis of sporadic and familial forms

International Journal of Cancer

Volumn 103, Issue 4, 2003, Pages 483-488

  Heinrich, Bianca ^a   Hartmann, Christian ^b   Stemmer Rachamimov, Anat O ^b   Louis, David N ^b   MacCollin, Mia ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MGH East Building 149 ^*  (United States)

Author keywords

Chromosome 18; Chromosome 22; DAL 1; Genetic analysis; Meningioma; Neurofibromatosis 2

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CHROMOSOME 18; CHROMOSOME 22; CLINICAL ARTICLE; CONTROLLED STUDY; DAL 1 GENE; FAMILIAL CANCER; GENE LOCUS; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MENINGIOMA; MOLECULAR MECHANICS; NEUROFIBROMATOSIS; NF2 GENE; PRIORITY JOURNAL; TUMOR CLASSIFICATION; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 22; DNA MUTATIONAL ANALYSIS; DNA RESTRICTION ENZYMES; EXONS; FAMILY HEALTH; FEMALE; FIBROBLASTS; HUMANS; INTRONS; LOSS OF HETEROZYGOSITY; MEMBRANE PROTEINS; MENINGIOMA; NEUROFIBROMIN 2; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TIME FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0037428665     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10840     Document Type: Article

References (24)

1. DeAngelis LM. Brain tumors. N Engl J Med 2001;344:114-23.
2. Wellenreuther R, Kraus JA, Lenartz D, Menon AG, Schramm J, Louis DN, Ramesh V, Gusella JF, Wiestler OD, von Deimling A. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol 1995;146:827-32.
3. Ruttledge MH, Sarrazin J, Rangaratnam S, Phelan CM, Twist E, Merel P, Delattre O, Thomas G, Nordenskjold M, Collins VP, Dumanski JP, Rouleau G et al. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet 1994;6:180-4.
4. Papi L, De Vitis LR, Vitelli F, Ammannati F, Mennonna P, Montali E, Bigozzi U. Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas. Hum Genet 1995;95:347-51.
5. De Vitis LR, Tedde A, Vitelli F, Ammannati F, Mennonna P, Bigozzi U, Montali E, Papi L. Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas. Hum Genet 1996;97:632-7.
6. Lekanne Deprez RH, Bianchi AB, Groen NA, Seizinger BR, Hagemeijer A, van Drunen E, Bootsma D, Koper JW, Avezaat CJJ, Kley N, Zwarthoff EC et al. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet 1994;54:1022-9.
7. Antinheimo J, Sankila R, Carpen O, Pukkala E, Sainio M, Jaaskelainen J. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 2000;54:71-6.
8. Turgut M, Palaoglu S, Ozcan OE, Gurcay O, Eryilmaz M. Multiple meningiomas of the central nervous system without the stigmata of neurofibromatosis. Clinical and therapeutic study. Neurosurg Rev 1997;20:117-23.
9. Nakasu S, Hirano A, Shimura T, Llena JF. Incidental meningiomas in autopsy study. Surg Neurol 1987;27:319-22.
10. Sieb JP, Pulst SM, Buch A. Familial CNS tumors. J Neurol 1992;239:343-4.
11. McDowell JR. Familial meningioma. Neurology 1990;40:312-4.
12. Heth JA, Kirby P, Menezes AH. Intraspinal familial clear cell meningioma in a mother and child. Case report. J Neurosurg 2000;93:317-21.
13. Maxwell M, Shih SD, Galanopoulos T, Hedley-Whyte ET, Cosgrove GR. Familial meningioma: Analysis of expression of neurofibromatosis 2 protein Merlin. Report of two cases. J Neurosurg 1998;88:562-9.
14. Stangl AP, Wellenreuther R, Lenartz D, Kraus JA, Menon AG, Schramm J, Wiestler OD, von Deimling A. Clonality of multiple meningiomas. J Neurosurg 1997;86:853-8.
15. Pulst SM, Rouleau GA, Marineau C, Fain P, Sieb JP. Familial meningioma is not allelic to neurofibromatosis 2. Neurology 1993;43:2096-8.
16. Tran YK, Bogler O, Gorse KM, Wieland I, Green MR, Newsham IF. A novel member of the NF2/ERM/4.1 superfamily with growth suppressing properties in lung cancer. Cancer Res 1999;59:35-43.
17. Perry A, Cai DX, Scheithauer BW, Swanson PE, Lohse CM, Newsham IF, Weaver A, Gutmann DH. Merlin, DAL-1 and progesterone receptor expression in clinicopathologic subsets of meningioma: A correlative immunohistochemical study of 175 cases. J Neuropathol Exp Neurol 2000;59:872-9.
18. Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepes JJ. Meningiomas. In: Kleihues P, Cavenee WK, eds. Pathology and Genetics of Tumours of the Nervous System. Lyon: International Agency for Research on Cancer, 2000. 175-184.
19. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, Gocayne JD, Amanatides P, et al. The sequence of the human genome. Science 2001;291:1304-51.
20. Patronas NJ, Courcoutsakis N, Bromley CM, Katzman GL, MacCollin M, Parry DM. Intramedullary and spinal canal tumors in patients with neurofibromatosis 2: MR imaging findings and correlation with genotype. Radiology 2001;218:434-42.
21. Jacoby LB, MacCollin M, Louis DN, Mohney T, Rubio MP, Pulaski K, Trofatter JA, Kley N, Seizinger B, Ramesh V, Gusella JF. Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 1994;3:413-9.
22. MacCollin M, Braverman N, Viskochil D, Ruttledge M, Davis K, Ojemann R, Gusella J, Parry DM. A point mutation associated with a severe phenotype of neurofibromatosis 2. Ann Neurol 1996;40:440-5.
23. Harada T, Irving RM, Xuereb JH, Barton DE, Hardy DG, Moffat DA, Maher ER. Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma. J Neurosurg 1996;84:847-51.
24. Gutmann DH, Donahoe J, Perry A, Lemke N, Gorse K, Kittiniyom K, Rempel SA, Gutierrez JA, Newsham IF. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas. Hum Mol Genet 2000;9:1495-500.